Cell Therapy Media Market

Cell Culture Consumables and Cell Culture Media Market (2nd Edition), 2023-2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    374

  • Pages
    250

  • View Count
    22297

Cell Therapy Media Market Overview

The global cell therapy media market size is estimated to grow from USD 1,176 million in 2023 to USD XX million by 2035, representing a CAGR of ~12% during the forecast period 2023-2035.

The therapeutic approach involving the injection of healthy cells in the human body to replace the diseased / non-functioning cells, in order to regulate certain functions, is referred to as cell therapy. In the past few years, this therapeutic approach has emerged as one of the key areas of interest in the healthcare sector, given its ability to treat diseases which were previously considered untreatable. Consequently, driven by the benefits offered by cellular therapies and recent approvals granted by regulatory authorities, the demand for cellular therapies has increased considerably; this has led to a rise in the requirement of cell therapy raw materials. Specifically, cell therapy consumables refer to materials that are used in the manufacturing of cell therapies. It is worth mentioning that the selection of cell therapy consumables, specifically the cell culture media and supplements, is a crucial step in cell therapy manufacturing as they directly impact the potency and safety of the final product.  In this cell culture consumables and cell culture media market report, we have considered the four predominant types of consumables applicable to cell therapy, namely cell culture media, media kits providing culture media along with the necessary media supplements, cell culture reagents and extracellular matrices. 

This image gives information on types of cell therapy consumables. Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes This infographic describes the market landscape of cell therapy kits. A larger proportion of the kits available in the cell therapy domain comprise of different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions This infographic describes the market landscape of cell therapy media. Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml

Key Market Insights

The Cell Culture Consumables and Cell Culture Media Market (2nd Edition): Distribution by Type of Product (Culture Media, Kits, Cell Culture Reagents and Extracellular Matrices), Type of Cell Therapy (T-Cell Therapy, Stem Cell Therapy, Dendritic Cell Therapy and NK Cell Therapy), Scale of Operation (Clinical and Commercial), Type of End User (Industry and Non-Industry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa (MENA) and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and the likely future potential of the cell culture media (supplied alone or in kits as a combination with cell growth supplements), cell culture reagents and ECM market, over the forecast period. It highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the cell therapy industry. Key inclusions of the cell therapy consumables and cell culture media market report are briefly discussed below.

Cell Culture Media Market Drivers: Growing Demand for Cell Therapies

Since the development of the first cell therapy, this therapeutic segment has garnered significant attention from researchers and medical practitioners. This can be attributed to the fact that cell therapies have been demonstrated to possess a vast potential in the treatment of rare disorders, which were previously considered incurable. The popularity of this therapeutic class of products can also be validated from the fact that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. It is also worth mentioning that over 35 cell and gene therapies have already been commercialized, across various geographical locations, till date. Notable examples of recently approved cell therapies include (in reverse chronological order) Breyanzi® (June 2022), Carvykti™ (February 2022) and Abecma® (March 2021). 

Need for High-Quality Cell Culture Consumables for Cell Therapy

Driven by the rise in popularity of cell therapies, there is a growth in demand for cell culture media, cell culture reagents and surfaces that support their production. It is worth mentioning that, amidst the increasing demand for such products, there is a rise in stringency from regulatory authorities to ensure that the quality of raw materials is good. Therefore, to meet the industry needs, cell therapy manufacturers are actively adopting serum free and xeno free products, which are known to reduce the risk of batch-to-batch variability.

Role of Cell Therapy Consumables and Cell Culture Media in Commercialization of Cell Therapies

Currently, the marketed cell-based therapies are exorbitantly priced. Even though, with the introduction of automation technologies in cell therapy bioprocessing, the cost and time required for development of such products has reduced significantly, there is still a considerable scope of improvement to make these therapies affordable. 

In this context, it is worth mentioning that consumables, including media, reagents and matrices, currently constitute nearly 25% of the overall cost of cell therapy manufacturing. Optimization of raw materials, by streamlining the production processes, can help mitigate wastage and further reduce the manufacturing cost. Moreover, for commercial applications, it is crucial to obtain consistent outcomes during the manufacturing process. Cell culture media, with chemically defined formulation, provides enhanced consistency for production purposes. 

Current Market Landscape of Cell Culture Media, Cell Culture Reagents and Other Consumables for Cell Therapy

The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Some of these players also claim to have developed GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells. Subsequently, cell culture media market represents majority share (57%) of consumables offered, followed by the share captured by media and supplement kits (26%), extracellular matrices (14%) and cell culture reagents (3%). The ancillary materials offered by these companies are available in various volumes and can be utilized for numerous functions, such as cell proliferation, cell differentiation and cell isolation. Recent developments in cell culture consumables and cell culture media industry indicate that participants are actively expanding their capacity and product portfolio in order to accommodate the current and anticipated demand for cell therapies.

Cell Culture Media Market Trends

In recent years, there has been a considerable rise in regulatory stringency as well as awareness related to disadvantages of using animal-based medica formulations, in the cell therapy domain. Specifically, animal-based media pose an undesirable risk of transfecting infectious agents. This has resulted in a shift towards the higher adoption of chemically defined, animal-component free (serum-free and xeno-free) media, in the cell culture media market. It is worth mentioning that, currently, majority of the cell culture media are being used for the development of stem cell therapies, followed by those intended for T-cell therapies.

Cell Therapy Consumables Market Drivers: Approval of Cell Therapies and Increase in the Number of Clinical Trials

One of the key drivers of the investments in this market is the success of previously commercialized cell therapies. More than USD 35 billion has already invested in cell therapy industry by private investors. In the last few years, cell therapies have offered a relatively more reliable approach for the treatment of rare diseases. According to a study published in 2019, the prevalence rate of rare diseases is about 263 to 446 million individuals, at any point of time. This necessitates the need for more such life-saving therapies. It is worth highlighting that, by 2030, close to 60 cell and gene therapies are anticipated to receive regulatory approval, further expanding the opportunities associated within the market. These factors will, in turn, lead to a surge in the requirement for quality consumables, driving significant market growth of the cell culture media industry.

Market Size of the Cell Culture Consumables and Cell Culture Media Market

Driven by the indubitably rising need for cell therapies, the market for cell culture media and other consumables for cell therapy manufacturing is anticipated to grow at a CAGR of 12%, during the forecast period 2023-2035. Specifically, in terms of scale of operation, the demand for consumable products for commercial operations are expected to expand rapidly with the anticipated approval of numerous cell therapies. Additionally, it is worth highlighting that more than 80% of the current cell culture consumables and cell culture market share is captured by players based in North America and Asia-Pacific. 

Key Companies in the Cell Culture Consumables and Cell Culture Media Market

Examples of key companies engaged in this industry (which have also been captured in this report) include BD Biosciences, Bio-Techne, CellGenix, Corning, Irvine Scientific (Acquired by FUJIFILM), Lonza, Miltenyi Biotech, Sartorius, STEMCELL Technologies and Thermo Fisher Scientific. This cell culture consumables and cell culture media market analysis includes and easily searchable excel database of all the companies engaged in this industry, worldwide.

The image looks at the competitive landscape across cell therapy extracellular matrices providers. In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios This image provides the list of potential strategic partners for players involved in this domain. We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings This infographic describes the pricing strategy matrix that is anticipated to assist players in evaluating the competitive market prices for their products

Recent Developments in Cell Culture Consumables and Cell Culture Media Market

Several recent developments have taken place in the field of cell therapy consumables. Some of these recent initiatives have been mentioned below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analyses.

  • In June 2023, STEMCELL Technologies entered into an agreement with PBS Biotech, under which the former is responsible for supplying 3D cell culture media to enable robust scale-up of human pluripotent stem cell cultures in the latter company’s single-use bioreactor.
  • In March 2023, GeminiBio, a leader in manufacturing of cell culture products and custom cGMP bioprocess liquids, announced the opening of a new, state?of?the?art cGMP bioprocess liquid manufacturing facility in California, US. As per the company’s website, the new facility will provide customers with custom manufactured cGMP cell culture media, buffers, and other process liquids in batch sizes up to 10,000 liters.

Scope of the Report

The study presents an in-depth analysis of the various firms / organizations that are engaged in this industry, across different segments as defined in the below table:

Key Report Attributes Details

Base Year

  • 2022
Forecast Period
  • 2023-2035
Market Size 2023
  • $ 1,176 Million

CAGR

  • ~12%
Type of Product
  • Extracellular Matrices
  • Kits
  • Media
  • Reagents 
Type of Cell Therapy
  • Dendritic cell therapy
  • NK cell therapy
  • Stem cell therapy
  • T-Cell therapy

Scale of Operation

  • Clinical
  • Commercial

Type of End-User

  • Industry
  • Non-Industry

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa (MENA)
  • Latin America

Key Companies Profiled

  • BD Biosciences
  • Bio-Techne
  • CellGenix
  • Corning
  • Irvine Scientific (Acquired by FUJIFILM)
  • Lonza
  • Miltenyi Biotech
  • Sartorius
  • STEMCELL Technologies
  • Thermo Fisher Scientific

Customization Scope

  • 15% Free Customization Option

PowerPoint Presentation (Complimentary)

  • Available

Excel Data Packs (Complimentary)

  • Market Landscape Analysis
  • Company Competitiveness Analysis
  • Brand Positioning Analysis
  • Recent Developments and Initiatives
  • Likely Partners Analysis
  • Roots Analysis Competitive Pricing Framework
  • Demand Analysis
  • Market Forecast and Opportunity Analysis

The market research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the market report includes:

  • A preface providing an introduction to the full report, Cell Culture Consumables and Cell Culture Media Market (2nd Edition), 2023-2035.
  • An executive summary of the insights captured during our research, offering a high-level view on the current state of the cell culture consumables and cell culture media market and its likely evolution in the mid-long term.
  • A general introduction to cell therapies, including details related to the development and manufacturing of such therapeutics products, with addition focus on role of raw materials in cell therapy production. It further provides a brief overview of the different types of cell culture consumables for cell therapies and key challenges associated with their development. 
  • A detailed assessment of the overall market landscape of companies offering cell culture consumables and cell culture media, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of product (kits, media, reagents and extracellular matrices), number and location of consumable facilities, accreditations received, type of end-user (industry and non-industry), cell culture media compatibility (serum free media, xeno free media and both), type of cell therapy (T-cell therapies, stem cell therapies, NK cell therapies, dendritic cell therapies and others), type of function (cell proliferation, cell expansion, cell differentiation, cell activation, cell isolation, cell attachment), kit components (supplements / reagents, growth / induction medium, expansion medium, differentiation medium and others), type of ECM coating (laminin, fibronectin, vitronectin, basement membrane extract and others), type of formulation (powder, liquid, pre-coated cultureware), shelf life (6-12 months, 13-18 months, 19-24 months and 25-36 months), scale of operation (discovery, preclinical, clinical and commercial), application area (research use and therapeutic use), storage temperature (refrigerated, frozen, ultra-low and room temperature), as well as volume of media, reagents and extracellular matrices. 
  • A detailed competitiveness analysis of companies operating in the cell culture consumable and cell culture media market (kits, media, reagents and extracellular matrices) based on supplier strength (in terms of years of experience and company size), portfolio strength (considering media compatibility, number of unique type of cell therapy, application area, product manufacturing practices and number of consumable facilities) and number of products offered. 
  • A detailed brand positioning analysis of prominent industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.
  • Elaborate profiles of key companies in cell therapy consumables and cell culture media market (shortlisted on the basis of portfolio strength and number of products offered); each profile includes a brief overview of the company, along with information on its cell therapy consumables focused product portfolio, consumable facilities, recent developments and an informed future outlook. 
  • An analysis of recent developments within the cell culture consumables and cell culture media market, highlighting information on several partnerships and collaborations, mergers and acquisitions, and expansion initiatives that have taken place within this industry, during the period 2016-2022.
  • A list of over 250 cell therapy developers that are anticipated to partner with cell culture consumables and cell culture media providers; these companies have been shortlisted based on several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.
  • A proprietary Roots Analysis competitive pricing framework, which analyzes the competitive position of various companies engaged in cell culture consumables and cell culture media market, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices). In addition, it presents an equation devised to calculate the likely price of cell therapy consumables based upon their characteristics.
  • An informed estimate of the annual demand for cell culture consumables and cell culture media (in terms of volume of media required for total number of cells), based on scale of operation and key geographical regions.
  • An in-depth discussion on the upcoming trends and future growth opportunities within the cell culture consumables and cell culture media market, featuring details related to the significance of automation in cell therapy manufacturing processes and benefits of single use technologies for production of cell therapies.

One of the key objectives of the market report was to estimate the current opportunity and the future growth potential of the cell culture consumables and cell culture media market over the coming years. We have provided an informed estimate on the likely evolution of the market for the forecast period, 2023-2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on relevant parameters, such as type of product (kits, media, reagents and extracellular matrices), type of cell therapy (t-cell therapies, stem cell therapies, dendritic cell therapies and NK cell therapies), scale of operation (clinical and commercial), type of end-user (industry and non-industry) and key geographical regions (North America, Europe, Asia-Pacific, MENA and Latin America). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios of the industry’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in cell culture consumables and cell culture media industry. The market report features detailed transcripts of interviews held with the following individuals:

  • Vice President, Business Development, Small Company, US
  • Director R&D, Cell Culture and Immunology, Large Company, India
  • Chief Operating Officer, Small Company, US

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

The infographic looks at the demand of various cell therapy consumables. In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy consumables; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies This image provides details on cell therapy consumables market size. A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy consumables market at an annualized rate of 12% The image provides segmentaion of cell therapy consumables market. The projected future opportunity for cell therapy consumable providers is expected to be well distributed across different types of end-users and key geographical regions

Frequently Asked Questions

Question 1: What are the factors driving the cell culture consumables and cell culture media market?

Answer: The growing demand for cell therapies, as a result of the increasing number of commercialized cell therapies and the rise in cell therapy focused clinical trials.

Question 2: How many companies are engaged in offering cell culture media for manufacturing of cell therapies?

Answer: Currently, more than 65 companies claim to offer different types of cell culture media for the growth, proliferation, expansion and differentiation of numerous types of cell therapies.

Question 3: How many companies are engaged in offering cell culture kits for manufacturing cell therapies?

Answer: At present, nearly 40 players claim to offer several types of kits required to manufacture cell therapies. These kits comprise of various key components, including supplements / reagents for isolation, activation and differentiation of cells, growth media, differentiation media and expansion media.

Question 4: How many cell culture media products are available in the market for culturing cell therapies?

Answer: The current market features the presence of nearly 260 cell culture media products, which can be used for the manufacturing of cell therapies intended for culturing of human cells.

Question 5: What are the partnership and collaboration trends in the cell culture consumables and cell culture media market?

Answer: At present, distribution agreements, mergers and acquisitions, and product commercialization agreements are the most common types of partnerships.

Question 6: Which geographical segment has the largest market share in the cell culture consumables and cell culture media market?

Answer: North America captures the largest market share in the current cell culture consumables and cell culture media market, followed by Asia-Pacific.

Question 7: How big is the cell culture consumables and cell culture media market?

Answer: The cell culture consumables and cell culture media market size for cell therapy is estimated to be worth over $1,176 million in 2023.

Question 8: What is the anticipated cell culture consumables and cell culture media market growth rate?

Answer: The cell culture consumables and cell culture media market is anticipated to grow at CAGR of ~12% during the forecast period.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com